NCT06983886

Brief Summary

The effect of local infiltration of tranexamic acid in orthognathic surgery remains unclear. This study was conducted to evaluate the difference in postoperative blood loss, measured by surgical drain output, following orthognathic surgery. The investigation involved a within-subject comparison, where each side of the mandible received a different local anesthetic solution: one side was infiltrated with a mixture of lidocaine with adrenaline and tranexamic acid, while the other side received lidocaine with adrenaline and normal saline.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for phase_1

Timeline
5mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
May 2025Sep 2026

First Submitted

Initial submission to the registry

May 1, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

May 1, 2025

Last Update Submit

May 14, 2025

Conditions

Keywords

Postoperative blood lossOrthognathic surgeryBilateral sagittal split ramus osteotomiesBSSOBSSROTranexamic acid

Outcome Measures

Primary Outcomes (1)

  • Postoperative blood loss

    Amount of surgical drain output

    24 hours and 48 hours after the end of intervention

Secondary Outcomes (9)

  • Postoperative pain score

    24 hours and 48 hours after the end of intervention

  • Postoperative edema

    At 48 hours and 1 week after the end of intervention

  • Surgical filed visibility

    Intraoperatively

  • Headaches (Adverse events of tranexamic acid)

    within one week after end of the intervention

  • Nausea vomiting (Adverse events of tranexamic acid)

    within one week after end of the intervention

  • +4 more secondary outcomes

Study Arms (2)

Lidocaine with adrenaline and normal saline solution

ACTIVE COMPARATOR

A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision. This solution will be used on either left or right side of mandible depends on the randomized result, and the other side will be given the solution of another arm.

Drug: Normal Saline Solution (NSS)Drug: Lidocaine (drug)

Lidocaine with adrenaline and tranexamic acid

EXPERIMENTAL

A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of tranexamic acid (50 mg/ml), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after completion of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before the surgical incision was made. This solution will be used on either left or right side of mandible depends on the randomized result, and the other side will be given the solution of another arm.

Drug: Tranexamic AcidDrug: Lidocaine (drug)

Interventions

A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of tranexamic acid (50 mg/ml), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after completion of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before the surgical incision was made.

Lidocaine with adrenaline and tranexamic acid

A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision.

Lidocaine with adrenaline and normal saline solution

A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS) or 5 ml of tranexamic acid (50 mg/ml) depends on allocated group, resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision.

Lidocaine with adrenaline and normal saline solutionLidocaine with adrenaline and tranexamic acid

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged 18-50 years
  • undergoing orthognathic surgery (Bilateral sagittal split ramus osteotomies (BSSRO), with or without Le Fort I maxillary osteotomy)
  • ASA physical status I-II

You may not qualify if:

  • Genioplasty in the operation
  • History of allergy to tranexamic acid
  • History of thromboembolic disorders
  • Use of medications affecting blood coagulation (antiplatelet or anticoagulants) within the past 2 weeks
  • History of cerebrovascular disease
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Bangkok, Bangkok, 10400, Thailand

Location

MeSH Terms

Conditions

Postoperative Hemorrhage

Interventions

Tranexamic AcidSaline SolutionLidocainePharmaceutical Preparations

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative Complications

Intervention Hierarchy (Ancestors)

Cyclohexanecarboxylic AcidsAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsCrystalloid SolutionsIsotonic SolutionsSolutionsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Central Study Contacts

Chanokchon Kongkergkiat, MD

CONTACT

Kachin Wattanawong, MD, RCST

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomization will be performed using a computer-generated sequence by a research staff member from the Department of Surgery to determine the side of intervention. For example, if the randomized value is 0, the left side will receive the intervention drug and the right side will serve as the control; if the value is 1, the right side will receive the intervention drug and the left side will serve as the control. Block randomization will be used to ensure balanced allocation between the two groups. The randomization result will be sealed in an opaque envelope, which will be opened in the operating room prior to surgery by a resident not involved in the surgical procedure. The envelope will contain the randomization assignment and instructions for drug preparation. This uninvolved resident will prepare two syringes labeled for the left (L) and right (R) sides accordingly. The randomization assignment will remain blinded to the subject, surgical team, evaluator.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chanokchon Kongkergkiat, M.D.

Study Record Dates

First Submitted

May 1, 2025

First Posted

May 21, 2025

Study Start

May 12, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

May 21, 2025

Record last verified: 2025-05

Locations